Uterine Fibroids and Adenomyosis

Uterine fibroids and adenomyosis are common gynecological conditions in patients presenting abnormal uterine bleeding (AUB), pain (dysmenorrhea and dyspareunia), and infertility. Uterine fibroids are benign myometrial tumors, and, conversely, adenomyosis is characterized by the presence of heterotopic endometrial glands and stroma within the myometrium. Although being different entities, they share symptoms and treatment options. Clinical characteristics and main diagnosis criteria for uterine fibroids and adenomyosis will be developed. Nowadays, treatment for fibroids and adenomyosis is intended to control symptoms trying to preserve future fertility up to menopausal status. In this chapter, we will review main management options currently available: surgical treatment (including radical and conservative surgery), nonsurgical options, and medical treatment. Lastly, both conditions are common among women of reproductive age, and they can alter fertility and pregnancy outcomes. Thus, in the last part, adenomyosis-related and myoma-related infertility will be reviewed, as long as reproduction implications. Similar content being viewed by others

American Association of Gynecologic Laparoscopists (AAGL). Advancing minimally invasive gynecology worldwide. AAGL Practice report: Practice guidelines for the diagnosis and Management of Submucous Leiomyomas. J Minim Invasive Gynecol. 2012;19(2):152–71. Andres MP, Borrelli GM, Ribeiro J, Baracat EC, Abrão MS, Kho RM. Transvaginal ultrasound for the diagnosis of Adenomyosis: systematic review and meta-analysis. J Minim Invasive Gynecol. 2018;25(2):257–64. Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):511–21. Borah BJ, Nicholson WK, Bradley L, Stewart EA. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209(4):319.e1–20. Bulun SE. Uterine Fibroids. N Engl J Med. 2013;369(14):1344–55. Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016;22(6):665–86. Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366(5):409–20. Donnez J, Courtoy GE, Donnez O, Dolmans MM. Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review. Reprod Biomed Online. 2018;37(2):216–23. Dueholm M. Transvaginal ultrasound for diagnosis of adenomyosis: a review. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):569–82. Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand. 2017;96(6):715–26. Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2018;51:119–37. Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–12. Esmya. Summary of Product Characteristics. 2012. last Updated 2018[Internet]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages%252Fmedicines%252Fhuman%252Fmedicines%252F002041%252Fhuman_med_001542.jsp&mid=wc0b01ac058001d124. Exacoustos C, Brienza L, Di Giovanni A, Szabolcs B, Romanini ME, Zupi E, et al. Adenomyosis: three-dimensional sonographic findings of the junctional zone and correlation with histology. Ultrasound Obstet Gynecol. 2011;37(4):471–9. Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol. 2011;18(4):428–37. Gracia M, Alcalà M, Ferreri J, Rius M, Ros C, Saco MA, et al. Ulipristal acetate improves Clinical symptoms in women with Adenomyosis and uterine Myomas. J Minim Invasive Gynecol. 2018;25(7):1274–80. Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101(2):472–487.e8. Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2012;5:CD005073. https://doi.org/10.1002/14651858.CD005073.pub3. Islam MS, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics. Hum Reprod Update. 2018;24(1):59–85. Jiang X, Thapa A, Lu J, Bhujohory VS, Liu Y, Qiao S. Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas. Eur J Obstet Gynecol Reprod Biol. 2014;177:38–43. Laughlin-Tommaso SK. Alternatives to hysterectomy: management of uterine Fibroids. Obstet Gynecol Clin N Am. 2016;43(3):397–413. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clin Evid. 2015;2015:814. Lumsden MA, Hamoodi I, Gupta J, Hickey M. Fibroids: diagnosis and management. BMJ. 2015;351:1–10. Munro MG. Classification of menstrual bleeding disorders. Rev Endocr Metab Disord. 2012;13(4):225–34. Munro MG, Critchley HOD, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011;95(7):2204–2208.e3. NICE. Heavy menstrual bleeding: assessment and management. NICE guideline. 2018. Available from: https://www.nice.org.uk/guidance/ng88/resources/heavy-menstrual-bleeding-assessment-and-management-pdf-1837701412549. Parazzini F, Tozzi L, Bianchi S. Pregnancy outcome and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:74–84. Pontis A, D’Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016;32(9):696–700. Purohit P, Vigneswaran K. Fibroids and Infertility. Curr Obstet Gynecol Rep. 2016;5:81–8. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(9):3146–54. Senturk LM, Imamoglu M. Adenomyosis: what is new? Womens Heal. 2015;11(5):717–24. Shwayder J, Sakhel K. Imaging for uterine Myomas and Adenomyosis. J Minim Invasive Gynecol. 2014;21(3):362–76. Singh SS, Belland L, Leyland N, von Riedemann S, Murji A. The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids. Am J Obstet Gynecol. 2018;218(6):563–572.e1. Soave I, Wenger JM, Pluchino N, Marci R. Treatment options and reproductive outcome for adenomyosis-associated infertility. Curr Med Res Opin. 2018;34(5):839–49. Spies JB. Current role of uterine artery embolization in the management of uterine fibroids. Clin Obstet Gynecol. 2016;59(1):93–102. Stewart EA. Uterine fibroids. Lancet. 2001;357(9252):293–8. Stewart EA. Clinical practice. Uterine Fibroids. N Engl J Med. 2015;372(17):1646–55. Struble J, Reid S, Bedaiwy MA. Adenomyosis: a Clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016;23(2):164–85. Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod. 2010;25(2):418–29. Taran FA, Weaver AL, Coddington CC, Stewart EA. Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study. Hum Reprod. 2010;25(5):1177–82. Van Den Bosch T, Dueholm M, Leone FPG, Valentin L, Rasmussen CK, Votino A, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the morphological uterus sonographic assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46(3):284–98. Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592–601. Vilos GA, Allaire C, Laberge P-Y, Leyland N, Vilos AG, Murji A, et al. The Management of Uterine Leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–78. Younes G, Tulandi T. Conservative surgery for Adenomyosis and results: a systematic review. J Minim Invasive Gynecol. 2018;25(2):265–76. Zepiridis LI, Grimbizis GF, Tarlatzis BC. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:66–73. Zupi E, Marconi D, Sbracia M, Exacoustos C, Piredda A, Sorrenti G, et al. Directed laparoscopic cryomyolysis for symptomatic leiomyomata: one-year follow up. J Minim Invasive Gynecol. 2005;12(4):343–6. Zupi E, Centini G, Sabbioni L, Lazzeri L, Argay IM, Petraglia F. Nonsurgical alternatives for uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:122–31. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2020 Springer Nature Switzerland AG About this entry Cite this entry Gracia, M., Carmona, F. (2020). Uterine Fibroids and Adenomyosis. In: Petraglia, F., Fauser, B. (eds) Female Reproductive Dysfunction . Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-03594-5_9-1 Download citation DOI: https://doi.org/10.1007/978-3-030-03594-5_9-1 Received: Accepted: Published: Publisher Name: Springer, Cham Print ISBN: 978-3-030-03594-5 Online ISBN: 978-3-030-03594-5 eBook Packages: Living Reference MedicineReference Module Medicine